Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A3461 HIV-1 integrase inhibitorSummary: Uesful for anti-HIV
-
A3618 MK-51721 CitationSummary: HCV NS3/4a protease inhibitor
-
A3619 MK-5172 hydrateSummary: HCV NS3/4a protease inhibitor
-
A3620 MK-5172 potassium saltSummary: HCV NS3/4a protease inhibitor
-
A3621 MK-5172 sodium saltSummary: HCV NS3/4a protease inhibitor
-
A3643 NarlaprevirSummary: HCV NS3 protease inhibitor
-
A3653 Nelfinavir MesylateSummary: HIV protease inhibitor,antiretroviral drug for HIV treatment
-
A3655 NesbuvirTarget: Nonstructural protein 5B (NS5B)Summary: NS5B polymerase inhibitor
-
A3690 OtamixabanTarget: Factor XaSummary: Direct factor Xa inhibitors,potent and selective
-
A3711 PF-03084014Summary: γ-secretase inhibitor